Vaxine Pty Ltd., Adelaide, Australia announced that it has entered into a formal collaboration with Medytox Inc., a Kore...
The Australian Physiotherapy Association (APA), the 26,000+ member strong industry body for some of the world’s mo...
Australia based Mayne Pharma Group Limited is pleased to announce the launch of butalbital acetaminophen and caffeine (B...
Australian medical supply innovator Big Start is being inundated with orders from around the world as companies seek to ...
Australia based Mesoblast Limited, leader in cellular medicines for inflammatory diseases, announced that it has success...
The Australian CRO, Avance Clinical, said there was a 34% increase in the number of international trials registered in A...
Essence Group, the leading provider of Internet of Things (IoT) based telecare solutions, have announced that their adva...
Tessara Therapeutics Pty Ltd, a Melbourne-based biotechnology company developing human mimetic tissues, has closed its R...
Norway based CEPI, the Coalition for Epidemic Preparedness Innovations has announced a ninth worldwide collaboration to ...
In one of the first COVID-19 clinical vaccine trials, US-based clinical-stage biotechnology company Novavax has selected...
Award-winning digital patient recruitment Platform GeoMap Clinical has announced the Patient Enrollment Guarantee for sp...
The Australian Government will provide a further $3 million to support frontline health workers with training and inform...
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced on 22 April 2020 that it has appointed PhD an...
The trial, led by Associate Professor Steven Tong, Infectious Diseases clinician at the Royal Melbourne Hospital (RMH) i...
Australian company SPEE3D has successfully developed and tested a fast and affordable way to 3D print anti-microbial cop...
The first COVID-19 vaccine to be tested outside of the USA, and only the third vaccine clinical trial in the world,...
The Centre for Digestive Disease (CDD) headed by Professor Thomas Borody has cured Crohn’s Disease as reported on ...
Biocon and Mylan have announced the launch of Fulphila®, a biosimilar to Neulasta® (pegfilgrastim) in Australia....
